Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer

Carcinogenesis

Volumn 24, Issue 10, 2003, Pages 1671-1676

  Gao, Wei Min ^a   Romkes, Marjorie ^b,e   Day, Richard D ^c   Siegfried, Jill M ^b,e   Luketich, James D ^d,e   Mady, Hussam H ^b,f   Melhem, Mona F ^b,f   Keohavong, Phouthone ^a,e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; PROTEIN P53; TOBACCO SMOKE;

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CAUSE OF DEATH; CELL TRANSFORMATION; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; EXCISION REPAIR; EXON; FEMALE; GENE MUTATION; GENETIC DIFFERENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDUSTRIALIZATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; SMOKING; SOMATIC MUTATION; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE; XERODERMA PIGMENTOSUM;

ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; DNA HELICASES; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENES, P53; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEINS; SMOKING; TRANSCRIPTION FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 0142185393     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg115     Document Type: Article

References (47)

1. Carbone,D. (1992) Smoking and cancer. Am. J. Med., 93, 13S-17S.
2. Hecht,S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
3. Greenlee,R.T., Murray,T., Bolden,S. and Wingo,P.A. (2000) Cancer statistics, 2000. CA Cancer J. Clin., 50, 7-33.
4. Wei,Q., Cheng,L., Hong,W.K. and Spitz,M.R. (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res., 56, 4103-4107.
5. Hecht,S.S. (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res., 424, 127-142.
6. Denissenko,M.F., Pao,A., Tang,M. and Pfeifer,G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430-432.
7. Vineis,P., Talaska,G., Malaveille,C., Bartsch,H., Martone,T., Sithisarankul,P. and Strickland,P. (1996) DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int. J. Cancer, 65, 314-316.
8. Friedberg,E.C., Walker,G.C. and Siede,W. (1995) DNA Repair and Mutagenesis. ASM Press, Washington DC.
9. Greenblatt,M.S., Bennett,W.P., Hollstein,M. and Harris,C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
10. Gao,W.-M., Mady,H.H., Yu,G.-Y., Siegfried,J.M., Luketich,J.D., Melhem,M.F. and Keohavong,P. (2003) Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types, Lung Cancer, 40, 141-150.
11. Chiba,I., Takahashi,T., Nau,M.M. et al. (1990) Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene, 5, 1603-1610.
12. Hollstein,M., Sidransky,D., Vogetstein,B. and Harris,C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
13. Husgafvel-Pursiainen,K., Boffetta,P., Kannio,A., Nyberg,F., Pershagen,G., Mukeria,A., Constantinescu,V., Fortes,C. and Benhamou,S. (2000) p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Cancer Res., 60, 2906-2911.
14. Kishimoto,Y., Murakami,Y., Shiraishi,M., Hayashi,K. and Sekiya,T. (1992) Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res., 52, 4799-4804.
15. Nigro,J.M., Baker,S.J., Preisinger,A.C. et al. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
16. Takahashi,T., Nau,M.M., Chiba,I., Birrer,M.J., Rosenberg,R.K., Vinocour,M., Levitt,M., Pass,H., Gazdar,A.F. and Minna,J.D. (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494.
17. Wei,Q., Cheng,L., Amos,C.I., Wang,L.E., Guo,Z., Hong,W.K. and Spitz,M.R. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl Cancer Inst., 92, 1764-1772.
18. Mohrenweiser,H.W. and Jones,I.M. (1998) Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat. Res., 400, 15-24.
19. Benhamou,S. and Sarasin,A. (2000) Variability in nucleotide excision repair and cancer risk: a review. Mutat. Res., 462, 149-158.
20. Batty,D.P. and Wood,R.D. (2000) Damage recognition in nucleotide excision repair of DNA. Gene, 241, 193-204.
21. Shen, M.R., Jones,I.M. and Mohrenweiser,H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58, 604-608.
22. Butkiewiez,D., Rusin,M., Enewold,L., Shields,P.G., Chorazy,M. and Harris,C.C. (2001) Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 22, 593-597.
23. Spitz,M.R., Wu,X., Wang,Y., Wang,L.E., Shete,S., Amos,C.I., Guo,Z., Lei,L., Mohrenweiser,H. and Wei,Q. (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res., 61, 1354-1357.
24. Wilson,D.M., 3rd and Thompson,L.H. (1997) Life without DNA repair. Proc. Natl Acad. Sci. USA, 94, 12754-12757.
25. Kubota,Y., Nash,R.A., Klungland,A., Schar,P., Barnes,D.E. and Lindahl,T. (1996) Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J., 15, 6662-6670.
26. Thompson,L.H., Brookman,K.W., Jones,N.J., Allen,S.A. and Carrano,A.V. (1990) Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol. Cell. Biol., 10, 6160-6171.
27. Thompson,L.H. and West,M.G. (2000) XRCC1 keeps DNA from getting stranded. Mutat. Res., 459, 1-18.
28. Caldecott,K.W., Aoufouchi,S., Johnson,P. and Shall,S. (1996) XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res., 24, 4387-4394.
29. Cappelli,E., Taylor,R., Cevasco,M., Abbondandolo,A., Caldecott,K. and Frosina,G. (1997) Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J. Biol. Chem., 272, 23970-23975.
30. Masson,M., Niedergang,C., Schreiber,V., Muller,S., Menissier-de Murcia,J. and de Murcia,G. (1998) XRCC1 is specifically associated with poly (ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol., 18, 3563-3571.
31. Marintchev,A., Robertson,A., Dimitriadis,E.K., Prasad,R., Wilson,S.H. and Mullen,G.P. (2000) Domain specific interaction in the XRCC1-DNA polymerase beta complex. Nucleic Acids Res., 28, 2049-2059.
32. Divine,K.K., Gilliland,F.D., Crowell,R.E., Stidley,C.A., Bocklage,T.J., Cook,D.L. and Belinsky,S.A. (2001) The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat. Res., 461, 273-278.
33. Ratnasinghe,D., Yao,S.X., Tangrea,J.A., Qiao,Y.L., Andersen,M.R., Barrett,M.J., Giffen,C.A., Erozan,Y., Tockman,M.S. and Taylor,P.R. (2001) Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 119-123.
34. Pastorelli,R., Cerri,A., Mezzetti,M., Consonni,E. and Airoldi,L. (2002) Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes. Int. J. Cancer, 100, 9-13.
35. Caggana,M., Kilgallen,J., Conroy,J.M., Wiencke,J.K., Kelsey,K.T., Miike,R., Chen,P. and Wrensch,M.R. (2001) Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol. Biomarkers Prev., 10, 355-360.
36. Lunn,R.M., Helzlsouer,K.J., Parshad,R., Umbach,D.M., Harris,E.L., Sanford,K.K. and Bell,D.A. (2000) XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis, 21, 551-555.
37. Seker,H., Butkiewicz,D., Bowman,E.D., Rusin,M., Hedayati,M., Grossman,L. and Harris,C.C. (2001) Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res., 61, 7430-7434.
38. David-Beabes,G.L., Lunn,R.M. and London,S.J. (2001) No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 911-912.
39. Duell,E.J., Wiencke,J.K., Cheng,T.J., Varkonyi,A., Zuo,Z.F., Ashok,T.D., Mark,E.J., Wain,J.C., Christiani,D.C. and Kelsey,K.T. (2000) Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 21, 965-971.
40. Matullo,G., Guarrera,S., Carturan,S., Peluso,M., Malaveille,C., Davico,L., Piazza,A. and Vineis,P. (2001) DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer, 92, 562-567.
41. Sturgis,E.M., Zheng,R., Li,L., Castillo,E.J., Eicher,S.A., Chen,M., Strom,S.S., Spitz,M.R. and Wei,Q. (2000) XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis, 21, 2219-2223.
42. Dybdahl,M., Vogel,U., Frentz,G., Wallin,H. and Nexo,B.A. (1999) Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 8, 77-81.
43. de Boer,J. and Hoeijmakers,J.H. (2000) Nucleotide excision repair and human syndromes. Carcinogenesis, 21, 453-460.
44. Park,J.Y., Lee,S.Y., Jeon,H.S. et al. (2002) Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol. Biomarkers Prev., 11, 23-27.
45. Lunn,R.M., Langlois,R.G., Hsieh,L.L., Thompson,C.L. and Bell,D.A. (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res., 59, 2557-2561.
46. Abdel-Rahman,S.Z. and El-Zein,R.A. (2000) The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett., 159, 63-71.
47. Hou,S.M., Ryk,C., Kannio,A., Angelini,S., Falt,S., Nyberg,F. and Husgafvel-Pursiainen,K. (2003) Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Environ. Mol. Mutagen., 41, 37-42.